Navigation Links
Varian Medical Systems Spotlights Advanced Radiosurgery Systems at ISRS Congress in Paris, May 8-12
Date:5/6/2011

PARIS, May 6, 2011 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is spotlighting its TrueBeam™ STx with Novalis® Radiosurgery program for fast and precise stereotactic radiosurgery cancer treatments at the International Stereotactic Radiosurgery Society (ISRS) congress in Paris next week. The Varian booth (Booth K) will focus on the capabilities of the company's TrueBeam™ STx with Novalis® Radiosurgery program for stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) applications, along with RapidArc® for volumetric modulated arc therapy.

"The ISRS Congress represents an important gathering of thought-leaders in the field of radiosurgery," said Rolf Staehelin, Varian's director, international marketing EMEA & APAC.  "The corner-stone of the clinical practice of radiosurgery are multidisciplinary teams of neurosurgeons, radiation oncologists and medical physicists, to name a few, and Varian is delighted to participate in such an important gathering."

"There are hundreds of radiosurgery-enabled Varian linear accelerators installed around the world and Varian machines are carrying out more stereotactic radiosurgery and stereotactic body radiotherapy treatments than those of any other manufacturer," he added.

"At many centers RapidArc has become the standard technique for SBRT treatments in lung, pancreatic, liver, kidney and other indications. TrueBeam STx with its high definition HD120™ MLC (multileaf collimator) allows the utilization of RapidArc with great precision."

Varian's TrueBeam system has been designed from the ground up to treat tumors with unprecedented speed and accuracy -- including tumors that move during treatment as the patient breathes in and out. Designed to advance the treatment of lung, liver, head and neck, and other types of cancer, TrueBeam features a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. With its High Intensity Mode, TrueBeam can deliver very high doses quickly and accurately, more than twice as fast as earlier generations of technology.  This unique capability is of particular importance for radiosurgical applications, where very large doses are delivered in a single treatment or only a few sessions.  

TrueBeam™ STx with Novalis® Radiosurgery program is a joint offering from Varian and Brainlab, optimized for radiosurgery.  In addition to imaging and treatment technology from Varian, this system incorporates additional imaging and patient positioning technologies from Brainlab, for additional efficiency, precision, and flexibility.

Varian is sponsoring an ISRS Emerging Technologies Symposium on Monday, May 9th. The symposium will be hosted by Professor John Adler, chief of new clinical applications for Varian, who will also present a paper on the company's vision for radiosurgery. Also speaking is Dr. Frank Lagerwaard, radiation oncologist at VU University Medical Centre in Amsterdam, Netherlands, who will detail the hospital's active radiosurgery program using Varian equipment, and Dr. Michael Schulder, Professor of Neurosurgery at Hofstra University School of Medicine and Director of the Brain Tumor Institute in Manhasset, NY.  Dr. Schulder will focus on the evolution of functional treatments from Functional Neurosurgery to Functional Radiosurgery.

With approximately 500 pre-registrants consisting of 35% neurosurgeons, 35% radiation oncologists and 30% other clinical and technical specialists in the field, this year's Paris ISRS meeting is likely to be the largest international gathering of the growing SRS/SBRT clinical specialty to date.  More information about the ISRS can be found at www.isrsy.org.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,500 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.


'/>"/>
SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The ARIA® for Radiation Oncology Information System from Varian Medical Systems Now Certified by Surescripts® for E-Prescribing
2. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2011
3. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
4. Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants
5. New Brachytherapy Applicator for Endometrial Cancer Patients Introduced at ABS 2011 by Varian Medical Systems
6. Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China
7. Varian Medical Systems to Exhibit New TrueBeam™ System for Image-Guided Radiotherapy at ChinaMed Exhibition in Beijing
8. First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital
9. Varian Medical Systems Schedules Second Quarter FY2011 News Release and Conference Call
10. Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test
11. Varian Medical Systems to Showcase New X-Ray Tubes and Flat Panel Detectors at the ECR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... York , May 23, 2016 ... report titled, " Exocrine Pancreatic Insufficiency Market - Global ... - 2023 ." According to the report, the exocrine ... CAGR of 8.3% from 2015 to 2023 to reach ... (EPI) is a condition characterized by the deficiency of ...
(Date:5/23/2016)... -- Non-invasive diagnostic test realizes the potential ... to be presented at Yissum’s booth, at IATI-BIOMED 2016 ... of the Hebrew University of Jerusalem announced today ... Ventures MKI, the technology investment arm of Morris Kahn ... for early detection of multiple diseases by analyzing circulating ...
(Date:5/23/2016)... 2016   Purdue Pharma L.P.  today announced ... with Egalet Corporation and Acura Pharmaceuticals, Inc. that ... the agreement the companies will exchange valuable patent ... companies to develop and sell several opioid pain ... reflects the commitment of Purdue Pharma to seek ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... Mental health watchdog Citizens Commission on ... and renowned professor of psychiatry Thomas Szasz, is continuing its protest against the use ... Death” exhibit in Atlanta, Georgia. The opening of the exhibit follows CCHR’s recent protest ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Loma Linda University ... new adult hospital and expanded Children’s Hospital. Over 3,000 people looked on as the ... Check out the event photo slidehsow. , During the program, Richard H. Hart, ...
(Date:5/24/2016)... ... , ... Backed by decades of experience, Metroloji Okulu works ... best suited solution to meet regulatory requirements. Their professional staff also performs on-site ... , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical data ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... Growing in ... growing trend, more gluten-free products are available and easily accessible. Whether someone chooses to ... to cater to a certain diet, King Kullen Grocery stocks their shelves with many ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... by 9.3 million people, or 10% over last year, according to data in ... under group policies was comparatively stable, with a slight decrease in risk-based groups ...
Breaking Medicine News(10 mins):